Aldeyra Therapeutics
About:
Aldeyra Therapeutics develops next-generation medicines to improve the lives of patients with immune-mediated diseases.
Website: http://www.aldeyra.com/
Twitter/X: aldeyraaldx
Top Investors: Hercules Capital
Description:
Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are first-in-class potential treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjögren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.
$287M
Burlington, Massachusetts, United States
2004-01-01
lroth(AT)theruthgroup.com
John E. Dowling, Thomas A. Jordan
11-50
2021-04-28
Public
© 2025 bioDAO.ai